Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

World Economic Forum Selects Labcyte as 2015 Technology Pioneer

Labcyte is recognized for enabling scientists to discover new therapeutics with its acoustic liquid handling system

August 27, 2014

Sunnyvale, CA

SUNNYVALE, California─August 27, 2014─Labcyte Inc., the company revolutionizing life science research with the Echo® acoustic liquid handler, was recognized by the World Economic Forum for demonstrating the ability to inspire and leverage creativity to develop transformative solutions. The recognition is based on Labcyte’s innovative use of sound energy to transfer liquids. Their technology has enabled scientists to discover new therapeutics, improve diagnostics and better prescribe targeted, patient-specific treatments.

Each year since 2000, the World Economic Forum has chosen a select number of Technology Pioneers from hundreds of applicants. Candidate companies are nominated by members, constituents and collaborators of the World Economic Forum and by the public. The 82-member selection committee – composed of distinguished technology and innovation experts, academics and venture capitalists – reviews each application before making its recommendation to the World Economic Forum.

 “Acoustic liquid handling is a major leap forward from traditional liquid handling systems,” said Mark Fischer-Colbrie, president and CEO of Labcyte Inc. “The ability to transfer liquids containing drugs, cells, DNA, assay reagents and other materials with great precision and accuracy – in increments as low as a billionth of a liter – can be used in hundreds of applications across all areas of life science research. Use of acoustic energy to avoid all of the deficiencies of pipetting has already resulted in discoveries of new drug-candidates, lower costs of molecular diagnostics and better selection of therapeutics for targeted patient treatment. The Echo liquid handler is used today by the world’s top pharmaceutical firms, academic institutions, genome centers, contract research organizations and diagnostic providers. It is the future of life science.”

“The impact of technology continues to accelerate in all domains of society,” said Fulvia Montresor, Director, Head of Technology Pioneers at the World Economic Forum. “To better understand the breadth and depth of this impact, CEOs and other leaders have come to depend on their interactions with the Technology Pioneers and their diverse and innovative solutions.”

Labcyte will be recognized for its achievements in a ceremony on September 11, at the eighth Annual Meeting of the New Champions in Tianjin, China. The Meeting is the foremost gathering in Asia on science, technology, innovation and entrepreneurship. It will bring together more than 1,500 leaders from business, government and research from over 90 countries. In addition to the Technology Pioneers, participants will also include the Forum’s Global Growth Companies, Young Global Leaders, Young Scientists, Social Entrepreneurs and Global Shapers, as well as its Members and Partners.

More information about the World Economic Forum’s Technology Pioneers program can be found at http://www.weforum.org/techpioneers.

About Labcyte Inc.
Labcyte, a global biotechnology tools company headquartered in Sunnyvale, California, is revolutionizing liquid handling. Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, precision medicine, and imaging mass spectrometry. Labcyte has 53 U.S. patents and others internationally. For more information, visit www.labcyte.com.




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP